TOKYO -- Japan aims to approve remdesivir as a treatment for the coronavirus in as little as a week, the health minister said Saturday, as Tokyo asked the U.S. to ensure it receives adequate supplies of the drug.
The moves follow emergency U.S. approval of remdesivir, developed by Gilead Sciences, on Friday. Japan's expedited authorization procedures allow reporting of domestic clinical trials to be postponed to a later date, meaning the antiviral drug could be approved by mid-May.
